Botswana may have overlooked early warning signs that could have prevented the distribution of substandard tuberculosis (TB) medicines, according to documents reviewed by Sunday Standard.
The World Bank had initially flagged lapses in the country’s quality-control mechanisms yet these alerts seemingly went unheeded allowing substandard medicines from an Indian manufacturer to reach patients this year.
The World Bank’s latest report “Botswana Health Emergency Preparedness, Response and Resilience Project Using the Multi-Phase Programmatic.
There's more to this story
But to keep reading, we need you to subscribe.
Investigative journalism is an indispensable part of a healthy society, but it's also expensive to produce. We are reliant on subscriptions to fund our work, and while you can enjoy most of our stories for free, a small number of premium features are reserved for subscribers.
You can subscribe for one week, a month or a full year - the choice is yours.
Save 77% on an annual subscription. Click here to find out how.
Existing subscribers can log in to keep reading here.
